Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Hims

By GLP-1 ScorecardUpdated

CoreAge Rx
Site position #1

Higher score

HimsFactor scores not reassessed.
Site position #56

Lower score

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 75.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Before you choose

Hims does not publish a semaglutide price, so its Hims review sets out what it does disclose, while the CoreAge Rx review explains the conditions attached to CoreAge Rx's figure. The semaglutide cost page compares published rates across the field. Ask Hims for a written total before treating either one as the cheaper choice.

If neither one fits, CoreAge Rx vs Hormonally Balanced and DrBrainRx vs Hims compare each of them with another graded program, and the list of alternatives to CoreAge Rx ranks the programs closest to CoreAge Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +10
92
82
Dose & formulationCoreAge Rx +10
88
78
Clinical oversightCoreAge Rx +38
93
55
Labs & monitoringCoreAge Rx +10
90
80
FulfillmentCoreAge Rx +11
95
84
Contract termsHims +13
67
80
CoreAge Rx · top barHims · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxHims
WeighScore89.5/10075.6/100
GradeB+C
Site position#1#56
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.Varies (branded medication plus separate membership)
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.Varies (branded medication plus separate membership)
CoverageUS only; therapy-specific state restrictions applySelected states; eligibility varies
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedYes
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Hims

Site position #56 · C

Factor scores not reassessed.

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Strengths

  • Branded oral and injectable options
  • Medication and membership prices presented separately

What to consider

  • Required membership adds to advertised medication prices
  • Membership does not guarantee a prescription

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard